Stewart W. Strong - 06 Aug 2021 Form 3 Insider Report for HAEMONETICS CORP (HAE)

Role
President, Global Hospital
Signature
/s/ Thomas V. Powers, attorney-in-fact for Mr. Strong
Issuer symbol
HAE
Transactions as of
06 Aug 2021
Net transactions value
$0
Form type
3
Filing time
16 Aug 2021, 16:18:24 UTC
Next filing
27 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HAE Common Stock 12,792 06 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HAE Non-qualified Stock Option (Right to Buy) 06 Aug 2021 Common Stock 8,966 $56.57 Direct F2
holding HAE Non-qualified Stock Option (Right to Buy) 06 Aug 2021 Common Stock 4,501 $103.37 Direct F3
holding HAE Non-qualified Stock Option (Right to Buy) 06 Aug 2021 Common Stock 4,358 $123.37 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 11,852 securities are in the form of unvested restricted stock units ("RSUs") issued pursuant to the Issuer's 2019 Long-Term Incentive Compensation Plan. Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested. 5,224 of such RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant, with shares vesting on various dates between October 2021 and May 2025. 6,628 of such RSUs vest in annual increments of 50% beginning on the first anniversary of the date of grant, with shares vesting in May 2022 and May 2023.
F2 Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
F3 Reflects options granted on May 18, 2020 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
F4 Reflects options granted on October 22, 2019 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.